NEUROCRINE BIOSCIENCES INC - NBIX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$17.26B

QoQ value delta ($000)

+$3.979B (+29.96%)

Implied price effect (QoQ)

+27.83%

Total shares

102,644,908

QoQ shares delta

+1,681,754 (+1.67%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 784 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	2,310,885	13,711,607	0.03%
JPMORGAN CHASE & CO	1,102,509	6,480,674	0.06%
DODGE & COX	941,218	5,584,707	0.49%
VANGUARD PORTFOLIO MANAGEMENT LLC	838,307	4,974,083	0.04%
VANGUARD CAPITAL MANAGEMENT LLC	766,048	4,545,339	0.02%
STATE STREET CORP	739,126	4,385,598	0.02%
AQR CAPITAL MANAGEMENT LLC	643,472	3,818,037	0.22%
RENAISSANCE TECHNOLOGIES LLC	393,680	2,335,897	0.54%
GEODE CAPITAL MANAGEMENT, LLC	359,607	2,138,777	0.02%
TWO SIGMA INVESTMENTS, LP	349,922	2,076,260	0.25%
Vestal Point Capital, LP	316,845	1,880,000	7.4%
BNP Paribas Asset Management Holding S.A.	251,858	1,494,259	0.25%
MORGAN STANLEY	222,231	1,318,607	0.01%
RTW INVESTMENTS, LP	213,689	1,267,925	1.82%
NORTHERN TRUST CORP	212,306	1,259,717	0.02%
Invesco Ltd.	181,565	1,077,317	0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	164,200	974,279	0.02%
NORGES BANK	164,132	973,880	0.02%
FIRST TRUST ADVISORS LP	155,578	923,125	0.09%
DIMENSIONAL FUND ADVISORS LP	123,525	732,877	0.02%
JACOBS LEVY EQUITY MANAGEMENT, INC	122,375	726,112	0.44%
Bank of New York Mellon Corp	117,826	699,125	0.02%
Swedbank AB	109,730	651,082	0.09%
VANGUARD FIDUCIARY TRUST CO	109,170	647,763	0.02%
GOLDMAN SACHS GROUP INC	108,804	645,592	0.01%